Alternate Health Club vs Claya
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Alternate Health Club
Best for patients who want compounded GLP-1 bundled with structured workout and dietary plans, at a competitive monthly price, and who are comfortable verifying state coverage + billing terms directly with the platformStarting at $129/mo
Claya
Best for Patients seeking a compounded GLP-1 platform with named clinician leadership and named pharmacy partners who want both injectable and oral-tablet form factors, and who are comfortable with the standard 503A-compounded supply chain.Starting at $179/mo
Side-by-Side Comparison
| Feature | Alternate Health Club | Claya |
|---|---|---|
| Overall Score | ✓7.3/10 | 7.0/10 |
| Starting Price | ✓$129/mo | $179/mo |
| Editorial Rating | ✓3.7 ★ /5 | 3.5 ★ /5 |
| Features | 6 features | ✓8 features |
| States Available | 0 | 0 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Alternate Health Club
Pros
- ✓$129/month compounded semaglutide is in the cheapest decile of the US compounded telehealth market
- ✓$169/month compounded tirzepatide is competitive with established compounded-tirz platforms
- ✓Complimentary workout & dietary plans included alongside medication — most peer platforms don't bundle this
- ✓LegitScript Verified seal displayed in the footer
- ✓U.S.-licensed clinicians explicitly mentioned
Cons
- ✗Parent company / legal entity name NOT publicly disclosed — material YMYL transparency gap
- ✗State of incorporation NOT disclosed
- ✗Per-state availability NOT enumerated — verify your state ships before committing
- ✗Pharmacy partners NOT publicly named — material YMYL transparency gap
- ✗Lab work NOT clearly disclosed as included
- ✗Billing cadence (monthly vs quarterly vs annual) NOT clearly disclosed on home page
- ✗First-month discount or trial offer NOT disclosed
Claya
Pros
- ✓Two named licensed clinicians (Habashy NMD MS and Barber MD PhD) — rare transparency for a compounded-GLP-1 platform
- ✓Two named 503A-pattern pharmacy partners with full addresses (RedRock UT + Healthware KY)
- ✓Both injectable AND oral-tablet compounded formulations offered for both semaglutide and tirzepatide
- ✓Weight-loss money-back guarantee published on homepage
- ✓Free expedited shipping included in monthly price
Cons
- ✗States-served list NOT disclosed on homepage or FAQ — buyers must check at checkout
- ✗LegitScript certification status NOT displayed on homepage
- ✗Corporate legal entity (LLC/Inc/PC) NOT disclosed on site or in privacy policy
- ✗Compounded oral tablets are an aggressive form factor — efficacy data vs injectable semaglutide is weaker (no STEP-equivalent oral compounded trials)
- ✗Tiered pricing structure (intro vs refill) creates first-month price advantage that disappears at refill
Our Verdict
Alternate Health Club edges out Claya with a higher overall score of 7.3/10 and is particularly strong for patients who want compounded GLP-1 bundled with structured workout and dietary plans, at a competitive monthly price, and who are comfortable verifying state coverage + billing terms directly with the platform. Claya remains a solid alternative, especially if you're looking for Patients seeking a compounded GLP-1 platform with named clinician leadership and named pharmacy partners who want both injectable and oral-tablet form factors, and who are comfortable with the standard 503A-compounded supply chain..
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.